Burning Rock Biotech (BNR) Net Income towards Common Stockholders: 2020-2025
Historic Net Income towards Common Stockholders for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to -$2.6 million.
- Burning Rock Biotech's Net Income towards Common Stockholders rose 60.20% to -$2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.2 million, marking a year-over-year increase of 75.79%. This contributed to the annual value of -$47.5 million for FY2024, which is 48.42% up from last year.
- Per Burning Rock Biotech's latest filing, its Net Income towards Common Stockholders stood at -$2.6 million for Q3 2025, which was down 85.34% from -$1.4 million recorded in Q2 2025.
- In the past 5 years, Burning Rock Biotech's Net Income towards Common Stockholders registered a high of -$1.4 million during Q2 2025, and its lowest value of -$44.3 million during Q4 2021.
- In the last 3 years, Burning Rock Biotech's Net Income towards Common Stockholders had a median value of -$14.8 million in 2024 and averaged -$13.2 million.
- As far as peak fluctuations go, Burning Rock Biotech's Net Income towards Common Stockholders tumbled by 59.45% in 2022, and later skyrocketed by 90.43% in 2025.
- Over the past 5 years, Burning Rock Biotech's Net Income towards Common Stockholders (MRQ) stood at -$44.3 million in 2021, then increased by 21.65% to -$34.7 million in 2022, then grew by 28.75% to -$24.7 million in 2023, then surged by 62.28% to -$9.3 million in 2024, then skyrocketed by 71.92% to -$2.6 million in 2025.
- Its last three reported values are -$2.6 million in Q3 2025, -$1.4 million for Q2 2025, and -$1.9 million during Q1 2025.